PS6K amplification characterizes a small subset of anaplastic meningiomas

American Journal of Clinical Pathology

Volumn 115, Issue 2, 2001, Pages 213-218

  Cai, D X ^a   James, C D ^a   Scheithauer, B W ^a   Couch, F J ^a   Perry, A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

FISH; Fluorescence in situ hybridization; Gene amplification; Meningioma; Prognosis; PS6K

Indexed keywords

DNA; PROTEIN SERINE THREONINE KINASE;

ARTICLE; BREAST CANCER; CANCER GRADING; CELL CYCLE; CHROMOSOMAL LOCALIZATION; CHROMOSOME 17Q; COMPARATIVE GENOMIC HYBRIDIZATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MENINGIOMA; ONCOGENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

DNA PRIMERS; DNA, NEOPLASM; GENE AMPLIFICATION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MENINGEAL NEOPLASMS; MENINGIOMA; NEOPLASM STAGING; PLANT PROTEINS; POLYMERASE CHAIN REACTION; PROTEIN-SERINE-THREONINE KINASES;

EID: 0035126321     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/FVNU-7UBY-DXE3-77MT     Document Type: Article

References (41)

1. DNA copy number amplifications in human neoplasms: Review of comparative genomic hybridization studies
2. Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: Toward a genetic model of meningioma progression
3. Detection of gains and losses in 18 meningiomas by comparative genomic hybridization
4. Malignant meningiomas frequently lose multiple chromosomal regions in addition to 22q: Putative meningioma progression loci identified by comparative genomic hybridization
5. TOR signaling and control of cell growth
6. s6k gene reveals a small mouse phenotype and a new functional S6 kinase
7. Drosophila S6 kinase: A regulator of cell size
8. Localization of PS6K to chromosomal region 17q23 and determination of its amplification in breast cancer
9. Meningioma grading: An analysis of histologic parameters
10. "Malignancy" in meningiomas: A clinicopathologic study of 116 patients
11. Meningiomas
12. Reliability of differential PCR for the detection of EGFR and MDM2 gene amplification in DNA extracted from FFPE glioma tissue
13. Merlin, DAL-1, and progesterone receptor expression in clinicopathologic subsets of meningioma: A correlative immunohistochemical study of 175 cases
14. Comparative genomic hybridization analysis of genetic alterations associated with malignant progression of meningioma
15. Detection of amplified DNA sequences by reverse chromosome painting using genomic tumor DNA as probe
16. Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas
17. Deletion mapping of the long arm of chromosome 22 in human meningiomas
18. Predominant occurrence of somatic mutations of the NF2 gene in meningiomas and schwannomas
19. Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors
20. Screening for mutations in the neurofibromatosis type 2 (NF2) gene in sporadic meningiomas
21. Molecular genetic investigation of the NF2 tumor suppressor gene in sporadic meningioma
22. Loss of merlin expression in sporadic meningiomas, ependymomas and schwannomas
23. Immunohistochemical detection of schwannomin and neurofibromin in vestibular schwannomas, ependymomas and meningiomas
24. Expression of neurofibromatosis 2 protein in human brain tumors: An immunohistochemical study
25. NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas
26. Tight association of loss of merlin expression with loss of heterozygosity at chromosome 22a in sporadic meningiomas
27. Analysis of the PTEN gene in human meningiomas
28. Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q
29. Analysis of cell cycle regulators: P16INK4A, pRb, and CDK4 in low-and high-grade meningiomas
30. Infrequent alterations of the p15, p16, CDK4 and cyclin D1 genes in non-astrocytic human brain tumors
31. Detection of TP53 gene mutation in human meningiomas: A study using immunohistochemistry, polymerase chain reaction/singlestrand conformation polymorphism and DNA sequencing techniques on paraffin-embedded samples
32. Molecular genetics of astrocytomas and meningiomas
33. Malignant meningioma in Gorlin's syndrome: Cytogenetic and p53 gene analysis: Case report
34. p73 gene transcripts in human brain tumors: Overexpression and altered splicing in ependymomas
35. s6K pathway in human pancreatic cancer cells
36. Integrin-dependent activation of the p70 ribosomal S6 kinase signaling pathway
37. p70 S6 kinase-mediated protein synthesis is a critical step for vascular endothelial cell proliferation
38. Molecular cloning and characterization of a novel p70 S6 kinase, p70 S6 kinase beta containing a proline-rich region
39. S6Kβdefines a novel family of p70 S6 kinases
40. Characterization of S6K2, a novel kinase homologous to S6K1
41. Cloning and characterization of a nuclear S6 kinase, S6 kinase-related kinase (SRK); A novel nuclear target of Akt